Pfizer, Moderna COVID-19 vaccines infringe new Alnylam patent, lawsuits say | Reuters

Summary; Law firms. Alnylam adds new RNA-delivery patent to vaccine disputes; Lawsuits filed same day Alnylam’s patent was issued.